Stats for the upcoming financialsQuartery Scorecard
Company Guidance (announced Nov 1, 2021 with Q3 results) "The Company expects to generate net revenues attributable to its core business of approximately $27.8 million to $28.8 million during the fourth quarter of 2021. While the Company's COVID-19 response related business has slowed during the current year, the Company is continuing to pursue additional sales and support revenues and estimates fourth quarter 2021 net revenues of approximately $1.5 million to $1.7 million related to the COVID-19 pandemic. Total net revenues for the fourth quarter of 2021 are estimated to be approximately $29.3 million to $30.5 million."
- Q3 2021 stats
- Total Revenue: 29,3
- Core Business revenue: 27.8
- Vent revenue: 21.3
- Other core revenue: 6.5
- Covid related revenue: 1.5
- Net Income: 1.8
- Adjusted Ebita: 7.4
- Cash balance: 26.9
- Vent patients 8200
- Q4 2020 Stats
- Total Revenue: 31.2
- Core Business revenue: 26.1
- Vent Revenue: 20.6
- Other core revenue: 5.5
- Covid related revenue: 5.1
- Net Income: 5.1
- Adjusted Ebita: 9.5
- Cash balance: 31.0
- Vent patients 7892
I will be looking for the growth in core business revenue and increase in vent patients. It should give us a window of what to expect in terms of growth for the balance of the 2022 year. One must factor out the last two weeks of Q4 2021 and the first six weeks of Q1 2022 when the Omicron wave overwhelmed hosptials.
I will be looking for longer term guidance for 2022 and, because of Omicron, not just Q1 2022.